» Articles » PMID: 15024186

Active Crohn's Disease Patients Show a Distinctive Expansion of Circulating Memory CD4+CD45RO+CD28null T Cells

Overview
Journal J Clin Immunol
Publisher Springer
Date 2004 Mar 17
PMID 15024186
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In a previous study we found an expansion of circulating memory (CD45RO(+)) CD4(+) T cells in patients with Crohn's disease (CD). The aim of this work was to investigate the phenotypic and functional characteristics of this T-cell subset in CD. We analyzed in peripheral blood CD4(+)CD45RO(+) T cells from CD patients the expression of surface markers associated to immune activation, costimulation, and apoptosis. In sorted CD4(+)CD45RO(+) T cells apoptosis was quantified by fluorescent annexin V binding. Healthy subjects and patients with ulcerative colitis and acute bacterial enterocolitis served as control groups. An increased percentage of memory CD4(+)CD45RO(+) T cells lacking the expression of costimulatory receptor CD28 was detected in patients with active CD when compared to the other groups evaluated. This expanded CD4(+)CD45RO(+)CD28(null) T-cell subset expressed mostly the effector-cell marker CD57(+). Both CD28 downregulation and CD57 expression correlated to CDAI and surrogate markers of disease activity. These phenotypic changes observed on CD4(+)CD45RO(+) T cells from active CD returned to values similar to healthy controls after clinical remission. Moreover, this memory CD28(null) T-cell subset might express more intracytoplasmic TNF and IFN-gamma than their CD28(+) counterpart. Significantly lower frequencies of memory CD4(+)CD45RO(+) T cells expressing CD95 apoptosis receptor were found in patients with active CD. Moreover, sorted CD4(+)CD45RO(+)and CD4(+)CD45RO(+) CD28(null) T cells from patients with active CD exhibited a lower apoptotic rate than that found in healthy controls and inactive CD patients. According to our data, circulating T lymphocytes from active CD patients show distinctive phenotypic and functional changes, characterized by an expansion of memory CD4(+)CD45RO(+)CD28(null) T cells expressing effector-associated cell surface molecules and displaying enhanced resistance to apoptosis.

Citing Articles

Exhausted Lag-3+ CD4+ T cells are increased in pediatric Inflammatory Bowel Disease.

Schnell A, Aicher C, Schnegelsberg P, Schwarz B, Schmidt H, Allabauer I Clin Exp Immunol. 2024; 219(1).

PMID: 39044534 PMC: 11771200. DOI: 10.1093/cei/uxae066.


Enhanced Th17 responses in the appendix of children with complex compared to simple appendicitis are associated with microbial dysbiosis.

The S, Schreurs R, Drewniak A, Bakx R, de Meij T, Budding A Front Immunol. 2024; 14:1258363.

PMID: 38239362 PMC: 10794624. DOI: 10.3389/fimmu.2023.1258363.


Pediatric IBD patients show medication and disease activity dependent changes in NK cell and CD4 memory T cell populations.

Pappa A, Muhrer J, Gast P, Subramanyam S, Ohl K, Muschaweck M Front Pediatr. 2023; 11:1123873.

PMID: 37456566 PMC: 10345343. DOI: 10.3389/fped.2023.1123873.


Unusual presentation of Crohn's disease.

Edwards K, Yearsley K BMJ Case Rep. 2021; 14(6).

PMID: 34108157 PMC: 8191605. DOI: 10.1136/bcr-2021-242703.


Introducing GATA3 as a prominent player in Crohn's disease.

Rezaei-Tavirani S, Asri N, Emamhadi M, Jahani-Sherafat S, Seyed Salehi A, Gholamrezaei Z Gastroenterol Hepatol Bed Bench. 2021; 13(Suppl1):S53-S59.

PMID: 33585004 PMC: 7881413.


References
1.
Hamann D, Baars P, Rep M, Hooibrink B, Klein M, van Lier R . Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med. 1997; 186(9):1407-18. PMC: 2199103. DOI: 10.1084/jem.186.9.1407. View

2.
Rulifson I, Sperling A, Fields P, Fitch F, Bluestone J . CD28 costimulation promotes the production of Th2 cytokines. J Immunol. 1997; 158(2):658-65. View

3.
Hogan L, Markofski W, Bock A, Barger B, MORRISSEY J, Sandor M . Mycobacterium bovis BCG-induced granuloma formation depends on gamma interferon and CD40 ligand but does not require CD28. Infect Immun. 2001; 69(4):2596-603. PMC: 98196. DOI: 10.1128/IAI.69.4.2596-2603.2001. View

4.
Podolsky D . Inflammatory bowel disease. N Engl J Med. 2002; 347(6):417-29. DOI: 10.1056/NEJMra020831. View

5.
Mariani P, Bachetoni A, dAlessandro M, Lomanto D, Mazzocchi P, Speranza V . Effector Th-1 cells with cytotoxic function in the intestinal lamina propria of patients with Crohn's disease. Dig Dis Sci. 2000; 45(10):2029-35. DOI: 10.1023/a:1005516730754. View